Immediate Impact
2 from Science/Nature 56 standout
Citing Papers
The present and future of bispecific antibodies for cancer therapy
2024 Standout
Targeting ROS in cancer: rationale and strategies
2024 Standout
Works of Ammar Adam being referenced
The Fully human anti-CD47 antibody SRF231 exerts dual-mechanism antitumor activity via engagement of the activating receptor CD32a
2020
A Dual Bcl-2/xL Inhibitor Induces Tumor Cell Apoptosis in a Hematopoietic Xenograft Model
2014
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Ammar Adam | 190 | 54 | 77 | 102 | 17 | 362 | |
| Hayato Urushima | 120 | 30 | 62 | 103 | 16 | 367 | |
| Xinxin Xiong | 169 | 20 | 52 | 76 | 17 | 385 | |
| David M. Cross | 179 | 19 | 28 | 124 | 18 | 379 | |
| Youxiang Ding | 241 | 30 | 64 | 81 | 16 | 383 | |
| Dianwen Ju | 169 | 17 | 89 | 63 | 17 | 397 | |
| Lawrence J. Dahm | 110 | 37 | 59 | 106 | 13 | 395 | |
| Darko Castven | 221 | 41 | 34 | 102 | 22 | 406 | |
| Shinan Li | 196 | 37 | 73 | 72 | 15 | 352 | |
| Xueting Shao | 182 | 21 | 93 | 86 | 14 | 397 | |
| Tiffany Cho | 190 | 16 | 67 | 170 | 15 | 401 |
All Works
Loading papers...